Acute Otitis Media Management
Acute Otitis Media
Etiology
Most common bacteria responsible for AOM:
· Streptococcus pneumoniae (approximately 40%)
· nontypable Haemophilus influenzae (25% to 30%)
· Moraxella catarrhalis (10% to 15%).
· Staphylococcus aureus and Streptococcus pyogenes are far less common causative agents
AOM cases attributed to viral infections:
· Rhinovirus
· Adenovirus
· Coronavirus
· Influenza
· respiratory syncytial virus
Occurrence/Epidemiology
· Most common precipitating event is a recent or concurrent URI
· The incidence rate of AOM increases during the winter months, when the climate is colder
· AOM is most common in very young children, with a peak incidence between 6 and 18 months
· Elderly adults also have a significant risk of developing disease because of decreases in natural immunity.
· Men and women are affected equally, although AOM tends to be rare in adults.
· AOM occurs in less than 1% of adults.
· Higher incidence among boys
Clinical Presentation
Subjective
· Fever
· Otalgia
· Irritability
· Crying
· sleep disturbance
· vomiting
· poor appetite
Physical examination findings
· Examination of the external ear in patients with OME is typically unremarkable
· bulging, erythematous, or opaque tympanic membrane
· absent or obscured bony landmarks and cone of light reflex
· lymphadenopathy of the preauricular and posterior cervical nodes is common during acute episodes
Diagnostic Testing
· Clinical diagnosis
· Otoscopy Examination
· CBC is usually not indicated; however, patients with AOM may demonstrate leukocytosis, particularly if they are febrile.
Differential Diagnosis
· Otitis externa- Differs from AOM, due to the inflammation of the auditory canal and external ear, including the pinna and tragus.
· TMJ syndrome pain- Differs from AOM because the pain is being referred from the TMJ.
· Mastoiditis - Differs from main diagnosis in that, there is edema, erythema, and tenderness over the mastoid process.
Non-Pharmacologic Management
· The ear canal should be kept as dry as possible
· Avoid using cotton swabs or sharp objects of any kind to clean the ears
· Feed child with the head elevated and avoid pacifiers when possible
· Delayed antibiotic therapy is an option in healthy patients 6 months or older with reliable follow-up
· A recommended approach is to provide analgesia and observe for 2 to 3 days. If the patient remains symptomatic after the observation period ends, the antibiotic is started.
Pharmacologic Management
1. Oral or rectal analgesia
Acetaminophen
· Neonates- Dose: 10-15 mg/kg PO q6-8h prn; Max: 60 mg/kg/day
· Infants/children- Dose: 10-15 mg/kg PO q4-6h prn; Max: 75 mg/kg/day up to 1 g/4h and 4 g/day
· 12 yo and older- Dose: 325-650 mg PO q4-6h prn; Max: 1 g/4h and 4 g/day
Ibuprofen
· 6 mo-11 yo- Dose: 5-10 mg/kg PO q6-8h prn; Max: 40 mg/kg/day
· 12 yo and older- Dose: 400 mg PO q4-6h prn; Max: 2400 mg/day
2. Antibiotics are prescribed in a stepwise fashion beginning with a first-line antibiotic
FIRST LINE TREATMENT RECOMMENDED
· amoxicillin: children: 80-100 mg/kg/day orally given in divided doses every 12 hours for 10 days
· amoxicillin/clavulanate: children >3 months of age: 80-100 mg/kg/day orally given in divided doses every 12 hours for 10 days more
Secondary Options
· cefdinir: children >6 months of age: 14 mg/kg/day for 10 days
· cefuroxime axetil: children: 30 mg/kg/day orally given in divided doses every 12 hours for 10 days
Tertiary Options
· azithromycin : children ≥6 months of age: 10 mg/kg/day orally (immediate-release) on the first day, followed by 5 mg/kg/day for 4 days; or 10 mg/kg/day orally (immediate-release) for 3 days; or 30 mg/kg/day orally (immediate-release) as a single dose; or 60 mg/kg/day orally (extended-release) as a single dose
· ceftriaxone: children: 50 mg/kg/day intramuscularly/intravenously for 3 days
Follow-up
· Patients with AOM should be seen for follow-up in 48 to 72 hours if symptoms have not resolved. Otherwise, a follow-up appointment may be scheduled several days after the completion of pharmacotherapy.
References
Armengol, C. (2019). Acute otitis media. Epocrates. Retrieved from
https://online.epocrates.com/diseases/3911/Acute-otitis-media/Key-Highlights
Dunphy, L.M., Winland-Brown, J.E., Porter, B.O. & Thomas, D.J. (2015). Primary Care: The
Art and Science of Advanced Practice Nursing, 4th Edition, Philadelphia: F.A. Davis
Company
Richardson, B. (2017). Pediatric Primary Care: Practice Guidelines for Nurses, 3rd Edition,
Burlington, MA. Jones & Bartlett Learning
Etiology
Most common bacteria responsible for AOM:
· Streptococcus pneumoniae (approximately 40%)
· nontypable Haemophilus influenzae (25% to 30%)
· Moraxella catarrhalis (10% to 15%).
· Staphylococcus aureus and Streptococcus pyogenes are far less common causative agents
AOM cases attributed to viral infections:
· Rhinovirus
· Adenovirus
· Coronavirus
· Influenza
· respiratory syncytial virus
Occurrence/Epidemiology
· Most common precipitating event is a recent or concurrent URI
· The incidence rate of AOM increases during the winter months, when the climate is colder
· AOM is most common in very young children, with a peak incidence between 6 and 18 months
· Elderly adults also have a significant risk of developing disease because of decreases in natural immunity.
· Men and women are affected equally, although AOM tends to be rare in adults.
· AOM occurs in less than 1% of adults.
· Higher incidence among boys
Clinical Presentation
Subjective
· Fever
· Otalgia
· Irritability
· Crying
· sleep disturbance
· vomiting
· poor appetite
Physical examination findings
· Examination of the external ear in patients with OME is typically unremarkable
· bulging, erythematous, or opaque tympanic membrane
· absent or obscured bony landmarks and cone of light reflex
· lymphadenopathy of the preauricular and posterior cervical nodes is common during acute episodes
Diagnostic Testing
· Clinical diagnosis
· Otoscopy Examination
· CBC is usually not indicated; however, patients with AOM may demonstrate leukocytosis, particularly if they are febrile.
Differential Diagnosis
· Otitis externa- Differs from AOM, due to the inflammation of the auditory canal and external ear, including the pinna and tragus.
· TMJ syndrome pain- Differs from AOM because the pain is being referred from the TMJ.
· Mastoiditis - Differs from main diagnosis in that, there is edema, erythema, and tenderness over the mastoid process.
Non-Pharmacologic Management
· The ear canal should be kept as dry as possible
· Avoid using cotton swabs or sharp objects of any kind to clean the ears
· Feed child with the head elevated and avoid pacifiers when possible
· Delayed antibiotic therapy is an option in healthy patients 6 months or older with reliable follow-up
· A recommended approach is to provide analgesia and observe for 2 to 3 days. If the patient remains symptomatic after the observation period ends, the antibiotic is started.
Pharmacologic Management
1. Oral or rectal analgesia
Acetaminophen
· Neonates- Dose: 10-15 mg/kg PO q6-8h prn; Max: 60 mg/kg/day
· Infants/children- Dose: 10-15 mg/kg PO q4-6h prn; Max: 75 mg/kg/day up to 1 g/4h and 4 g/day
· 12 yo and older- Dose: 325-650 mg PO q4-6h prn; Max: 1 g/4h and 4 g/day
Ibuprofen
· 6 mo-11 yo- Dose: 5-10 mg/kg PO q6-8h prn; Max: 40 mg/kg/day
· 12 yo and older- Dose: 400 mg PO q4-6h prn; Max: 2400 mg/day
2. Antibiotics are prescribed in a stepwise fashion beginning with a first-line antibiotic
FIRST LINE TREATMENT RECOMMENDED
· amoxicillin: children: 80-100 mg/kg/day orally given in divided doses every 12 hours for 10 days
· amoxicillin/clavulanate: children >3 months of age: 80-100 mg/kg/day orally given in divided doses every 12 hours for 10 days more
Secondary Options
· cefdinir: children >6 months of age: 14 mg/kg/day for 10 days
· cefuroxime axetil: children: 30 mg/kg/day orally given in divided doses every 12 hours for 10 days
Tertiary Options
· azithromycin : children ≥6 months of age: 10 mg/kg/day orally (immediate-release) on the first day, followed by 5 mg/kg/day for 4 days; or 10 mg/kg/day orally (immediate-release) for 3 days; or 30 mg/kg/day orally (immediate-release) as a single dose; or 60 mg/kg/day orally (extended-release) as a single dose
· ceftriaxone: children: 50 mg/kg/day intramuscularly/intravenously for 3 days
Follow-up
· Patients with AOM should be seen for follow-up in 48 to 72 hours if symptoms have not resolved. Otherwise, a follow-up appointment may be scheduled several days after the completion of pharmacotherapy.
References
Armengol, C. (2019). Acute otitis media. Epocrates. Retrieved from
https://online.epocrates.com/diseases/3911/Acute-otitis-media/Key-Highlights
Dunphy, L.M., Winland-Brown, J.E., Porter, B.O. & Thomas, D.J. (2015). Primary Care: The
Art and Science of Advanced Practice Nursing, 4th Edition, Philadelphia: F.A. Davis
Company
Richardson, B. (2017). Pediatric Primary Care: Practice Guidelines for Nurses, 3rd Edition,
Burlington, MA. Jones & Bartlett Learning
Comments
Post a Comment